Canton Biologics

Canton Biologics is a globally integrated CDMO, operating four core sites across China and Germany and serving over 100 biopharma clients worldwide. Our capabilities span six advanced solution areas: Innovative Drug Solutions, Biosimilar Solutions, ATMP Solutions (including oncolytic viruses, CAR-T cell therapies, LBPs, and exosome-based therapies), Biologics Solutions for Companion Animals, Biologics Solutions for Livestock and Poultry, and Recombinant Products for Healthcare & Lifestyle. Supported by robust quality systems aligned with EMA, FDA, and NMPA standards, we enable the development of even the most challenging-to-express proteins.